News: 2017

Shore Capital Partners Announces Closing of Fund II with $190 Million in Commitments

April 4, 2017 ‐ Shore Capital Partners (“Shore” or the “Firm”), a strategic private equity firm focused exclusively on the healthcare industry, today announced the first and final close of its second institutional private equity fund, Shore Capital Partners Fund II (“Fund II”), at the hard cap of $190 million.

Fund II, raised in less than three months, surpassed its original target of $150 million and was substantially oversubscribed with investor demand approaching $750 million. Fund II will continue the successful investment strategy employed by the Firm’s predecessor fund and invest primarily in control buyouts, focusing on microcap healthcare businesses. With Fund II, […]

Shore Capital Partners announced formation of EyeSouth Partners, completes affiliation with Georgia Eye Partners

March 14, 2017 – Shore Capital Partners (“Shore Capital” or “Shore”) is pleased to announce that it has formed EyeSouth Partners, LLC and completed a strategic partnership with Georgia Eye Partners (“Georgia Eye” or the “Company”). Founded in 1999 by Dr. Eugene Gabianelli, Georgia Eye is a leading eye care practice with four locations in the Atlanta, Georgia area. The Company offers medical and surgical specialty eye care services, including treatment for cataracts, corneal disease, refractive surgery, glaucoma, and oculoplastics through OPAL Aesthetics.

Shore Capital is proud to partner with Georgia Eye’s three partner physicians, Dr. Eugene Gabianelli (“Gino”), Dr. Andrew Feinberg (“Andrew”), […]

Shore Capital Partners announced an investment in Argentum Medical

January 20, 2017 – Shore Capital Partners (“Shore Capital” or “Shore”) today announced that it has completed a growth investment in Argentum Medical, LLC and certain assets of Cura Surgical, Inc. (“Argentum” or the “Company”). Founded in 2001 and located in Geneva, IL, Argentum manufactures and sells innovative wound care products across a wide number of clinical applications, including the Silverlon® (“Silverlon”) brand, its rapidly-growing, proprietary range of silver-based antimicrobial products.

The core platform technology in Silverlon is a uniquely designed silver-plated nylon matrix that provides the powerful antimicrobial properties of silver ions in the dressing without staining the skin and without increasing bioburden. […]